"Designing Growth Strategies is in our DNA"
The increased intake of high-sugar food, refined carbs, unhealthy fats, processed foods, and consumption of other unhealthy food leads the human body to release too much stress hormone, further activating microglia and astrocytes. Activation of these glial cells in the central nervous system (CNS) causes problems with the brain's cognitive functions and develops symptoms of impaired memory and learning.
The other reasons affecting the functioning of the human brain are infections caused by viruses and bacteria. Also, repeated exposure to toxic chemicals, such as lead or mercury, contributes to the symptoms of impaired brain functioning. Therefore, the increasing procurement of unhealthy diets and the rising exposure of people to several infectious diseases is leading to an increase in the prevalence of the population with the nervous system.
This rising prevalence of impaired cognitive functioning, loss of memory focus, and several people suffering from various nervous system disorders encouraged supplement manufacturers to focus on research and development of brain health supplements. This emphasis of manufacturers on research and development of a new product can assist in introducing a new product to the market and aid people in relieving nerve conditions. In addition to this several brain health supplement manufacturers are focusing on including natural ingredients in their products that are beneficial for the overall health and well-being of the human body.
The emergence of COVID-19 has impeded the demand for brain health supplements, as the healthcare professionals in hospitals addressed only severe neurological disorder cases. Therefore, the reduced number of patients visit hospitals and disruptions in the supply chains have majorly affected the sales of brain health supplements. For instance, the nutrition segment of Reckitt Benckiser Group PLC., generated a revenue of USD 4,053.0 million in 2020, witnessing a decline of 2.0% as compared to USD 4,134.4 million in 2019.
However, as many countries have relaxed travel restrictions post-pandemic, the number of patient visits to the hospital increased, leading to increased sales of brain health supplement products.
The report will cover the following key insights:
Nootropic supplements are expected to grow at an optimum growth rate during the forecast period. As we age, our bodies are less likely to absorb vitamins such as Vitamin B12, which can aid in the prevention of dementia and also boosts the production of neurotransmitters. This demonstrates that the aging population has a specific need for natural molecules, which nootropics can address. The other benefits that nootropics can offer are improved mental processing speed and cognitive health. Therefore, the growing interest of the general population in natural and preventative health measures and dietary supplements has increased the demand for nootropic products. Along with this, the emphasis of brain health supplement manufacturers on research and development of new products targeting specific disease areas contributes to the segment's growth.
To gain extensive insights into the market, Request for Customization
The increasing ageing population and the poor and unhealthy diet followed by people across regions are contributing to the rising prevalence of diseases related to the nervous system. The rising prevalence of neurological disease increased the demand for brain health supplesments. This rising demand for brain health supplements has brought business opportunities for many manufacturers. For this, they have devised different initiatives and campaigns for increasing awareness of the disease and how the utilization of supplements can aid in improving one’s condition.
The report will include the profiles of key players such as Reckitt Benckiser Group PLC., NEUROHACKER COLLECTIVE, LLC, SOMA Analytics, NOW Foods, Alternascript., Purelife Bioscience Co., Ltd., Opti-Nutra Ltd., and others.
The emphasis of key manufacturers on developing new brain health supplements and launching initiatives for raising awareness of nervous system-related diseases and penetration of their products in the market is contributing to the market's growth.
By Type | By Distribution Channel | By Region |
|
|
|